Ocular Therapeutix Inc (OCUL) President & CEO Antony C. Mattessich Bought $119,000 of Shares

GuruFocus.com
0
In this article:

- By insider

President & CEO of Ocular Therapeutix Inc (OCUL) Antony C. Mattessich bought 20,000 shares of OCUL on 08/20/2018 at an average price of $5.95 a share. The total cost of this purchase was $119,000.

Ocular Therapeutix Inc is a biopharmaceutical company. It is engaged in developing and commercializing therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Ocular Therapeutix Inc has a market cap of $236.180 million; its shares were traded at around $6.12 with and P/S ratio of 98.73. Ocular Therapeutix Inc had annual average EBITDA growth of 18.30% over the past five years.


CEO Recent Trades:

  • President & CEO Antony C. Mattessich bought 20,000 shares of OCUL stock on 08/20/2018 at the average price of $5.95. The price of the stock has increased by 2.86% since.

  • President and CEO Antony C. Mattessich bought 16,900 shares of OCUL stock on 08/10/2018 at the average price of $6.23. The price of the stock has decreased by 1.77% since.

CFO Recent Trades:

  • CFO Donald Notman bought 12,500 shares of OCUL stock on 08/14/2018 at the average price of $6.29. The price of the stock has decreased by 2.7% since.

For the complete insider trading history of OCUL, click here

.This article first appeared on GuruFocus.


Advertisement

Recommended Stories